© 2022 MJH Life Sciences and Drug Topics. All rights reserved.
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
April 26, 2021
Real-world data comparing erenumab with oral preventive medications was presented at the American Academy of Neurology’s 73rd Annual Meeting.
April 20, 2021
A study presented at the American Academy of Neurology’s 73rd Annual Meeting explored the fundamental barriers to good medical outcomes in migraine.
April 07, 2021
A 25-year study examines triptan use as an acute treatment strategy for migraines in a Danish population.
April 06, 2021
Experts discussed clinical questions regarding migraine treatments and COVID-19 vaccines.
March 31, 2021
Investigators offer a review of the most recent literature depicting the relationship between estrogen and the incidence of migraine headache.
If approved, atogepant will be the first oral CGRP receptor specifically developed for the preventive treatment of migraine.
March 19, 2021
A recent analysis evaluated the role of dietary magnesium consumption for migraine.
March 12, 2021
Research presented during the APhA 2021 Annual Meeting and Exposition examined the clinical use of ketamine as an abortive therapy for migraines and primary headaches.
March 09, 2021
The study findings will be presented at the American Academy of Neurology’s 73rd Annual Meeting.
March 08, 2021
Migraine is frequently comorbid with asthma. A new analysis examines whether there is a direct relationship between the 2 diseases.